IP Verse

Proprev competitive analysis

Loading summary...

Latest patents of Proprev opposed by its competitors

Explore Proprev's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3016527
Jul 25, 2018Treatment Of Obesity, The Metabolic Syndrome, Type 2 Diabetes, Cardiovascular Diseases, Dementia, Alzheimer'S Disease And Inflammatory Bowel Disease By Using At Least One Bacterial Strain From Prevotella1

Latest publications and patents of Proprev New

Explore the latest publications and patents granted to Proprev, showcasing their recent innovations and technological advancements.

Last updated on: Oct 21, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Proprev

EP3016527
Jul 25, 2018Treatment Of Obesity, The Metabolic Syndrome, Type 2 Diabetes, Cardiovascular Diseases, Dementia, Alzheimer'S Disease And Inflammatory Bowel Disease By Using At Least One Bacterial Strain From PrevotellaOpposition Rejected

Latest PTAB cases involving Proprev

Discover the latest PTAB cases involving Proprev, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Proprev with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
PROPREV - 1 - -
DUPONT NUTRITION BIOSCIENCES APS2815 - -